Development of new combined system for production of FDG and NAF radiopharmaceuticals

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

In this work, we present a new combined system which produces FDG and NaF in separate runs. The needed 18F for synthesis these radiopharmaceuticals are obtained by bombardment of highly enriched water (H2O18) with proton. The aim is development of routine systems to use with baby cyclotrons. In this study, the various chemical steps and required reagents as well as different reagent delivery methods has been investigated. This evaluation has been done with purpose of optimizing the performance of a conceptually simple device integrated into a fully automated synthesis procedure for radiosynthesis of FDG and NaF. In this system, we have used AVR microcontroller to control the process and LabVIEW software for monitoring the operation of system. Furthermore, Geiger Muller counters have been used to determine the activity to insure the accuracy of the systems operation.

Original languageEnglish
Title of host publicationCYCLOTRONS 2013 - Proceedings of the 20th International Conference on Cyclotrons and their Applications
PublisherJoint Accelerator Conferences Website (JACoW)
Pages390-392
Number of pages3
ISBN (Electronic)9783954501281
StatePublished - Mar 2014
Event20th International Conference on Cyclotrons and their Applications, CYCLOTRONS 2013 - Vancouver, Canada
Duration: 16 Sep 201320 Sep 2013

Publication series

NameCYCLOTRONS 2013 - Proceedings of the 20th International Conference on Cyclotrons and their Applications

Conference

Conference20th International Conference on Cyclotrons and their Applications, CYCLOTRONS 2013
Country/TerritoryCanada
CityVancouver
Period16/09/1320/09/13

Keywords

  • AVR microcontroller
  • FDG and NAF radiopharmaceutical
  • Geiger Muller counter
  • Highly enriched water
  • LabVIEW

Fingerprint

Dive into the research topics of 'Development of new combined system for production of FDG and NAF radiopharmaceuticals'. Together they form a unique fingerprint.

Cite this